Skip to main content

Table 1 Overview of the study period (SPIRIT Fig. 2013). PS performance status, MRI magnetic resonance imaging, and BMD bone mineral density

From: The clinical trial of alternative relugolix administration for uterine leiomyoma prior to surgically treatment: a study protocol for Non-Adverse Relugolix Administration (NARA) trial

  1. Participants will be checked for adverse effect existence, vital sign calculation, physical measurements, and performance status evaluation every visit. Questionnaires, laboratory tests, and imaging (ultrasound, MRI, and BMD) will be conducted before, 8 weeks, and after the start of the relugolix administration
  2. ECOG-PS Eastern Cooperative Oncology Group Performance Status, MRI magnetic resonance imaging, BMD bone mineral density
Back to article page

Trials

ISSN: 1745-6215